Restrictions on antibiotic growth promoters are reshaping feed formulation decisions and procurement priorities, pushing producers toward biological and functional alternatives that can preserve performance without creating regulatory exposure. In the eubiotics market, This trend is increasing demand for probiotics, prebiotics, organic acids, and phytogenics as nutrition programs are redesigned to support gut balance, feed conversion, and disease resilience under tighter compliance standards. Feed mills and integrators are increasingly embedding these products into routine rations rather than treating them as niche additives, which is supporting market development through more standardized usage and longer-term supply relationships.
Rising global meat consumption increasing demand for gut health–enhancing animal feed additives
As meat consumption rises, livestock and poultry producers face pressure to increase output while limiting losses from poor digestion, inconsistent weight gain, and enteric health challenges. That operating environment is reinforcing market demand for products that help animals extract more value from feed and maintain stable growth under intensive production systems. In the eubiotics market, gut health–enhancing additives are gaining wider adoption because they support more predictable herd and flock performance, which matters when producers are trying to meet higher throughput targets without proportionally increasing feed waste, mortality, or veterinary intervention.
Expanding precision livestock nutrition solutions improving feed efficiency and animal immunity outcomes
The spread of precision nutrition is changing how feed additives are selected, moving purchasing decisions away from broad supplementation and toward targeted inclusion based on species, life stage, health status, and production goals. This is aiding market expansion for specialized eubiotic formulations that can be matched to measurable outcomes such as feed efficiency, gut integrity, and immune response. In the eubiotics market, suppliers that can align products with data-driven feeding programs are benefiting from stronger integration into commercial nutrition strategies, since producers increasingly expect additives to deliver performance improvements that can be monitored and adjusted in real production settings.
| Growth Driver Assessment Framework | |||||
| Growth Driver | Impact On CAGR | Regulatory Influence | Geographic Relevance | Adoption Rate | Impact Timeline |
|---|---|---|---|---|---|
| Antibiotic ban regulations accelerating adoption of probiotics and feed alternatives in livestock nutrition | 2.40% | High | Europe, North America | High | Near Term |
| Rising global meat consumption increasing demand for gut health–enhancing animal feed additives | 2.10% | Moderate | Asia Pacific, Latin America | High | Mid Term |
| Expanding precision livestock nutrition solutions improving feed efficiency and animal immunity outcomes | 1.70% | Moderate | Europe, Asia Pacific | Emerging | Long Term |
Europe held the largest regional share of the eubiotics market in 2025, supported by the region’s mature animal nutrition industry, well-established feed production systems, and strong adoption of performance-enhancing and gut-health-oriented feed inputs. Demand is aided by the practical need to improve feed efficiency, maintain livestock health, and support productivity across intensive poultry, swine, and ruminant operations. The region’s structured regulatory environment and advanced livestock management practices also help sustain steady use of eubiotics in commercial feed formulations, particularly where producers prioritize consistent animal performance and controlled input quality.
Asia Pacific is projected to expand at a 9.94% CAGR over the forecast period, with the eubiotics market gaining momentum as livestock and aquaculture production continue to scale across major consuming economies. Growth is being propelled by the increasing shift toward more organized feed practices, where producers are adopting nutritional solutions that support animal health, digestion, and output quality under rising production pressure. As commercial farming operations modernize and feed manufacturers respond to higher demand for efficient, health-supportive formulations, adoption is accelerating in practical, volume-driven segments of regional animal production.
| Regional Market Attractiveness & Strategic Fit Matrix | |||||
| Parameter | North America | Asia Pacific | Europe | Latin America | MEA |
|---|---|---|---|---|---|
| Innovation Hub | Advanced | Developing | Advanced | Nascent | Developing |
| Cost-Sensitive Region | Medium | High | Medium | High | High |
| Regulatory Environment | Supportive | Neutral | Restrictive | Neutral | Neutral |
| Demand Drivers | Strong | Strong | Strong | Weak | Weak |
| Development Stage | Developed | Developing | Developed | Emerging | Emerging |
| Adoption Rate | High | Medium | High | Low | Low |
| New Entrants / Startups | Dense | Dense | Moderate | Sparse | Sparse |
| Macro Indicators | Strong | Stable | Stable | Weak | Weak |
The U.S. eubiotics market prioritizes feed solutions that improve animal health, digestive performance, and production efficiency. Producers increasingly adopt probiotics, prebiotics, and phytogenic additives to support sustainable livestock management and reduce antibiotic dependence.
Japan integrates eubiotics into high-quality livestock nutrition programs designed to improve gut health and consistent production performance. Companies prioritize advanced feed formulations supported by research and stringent quality standards.
South Korea expands eubiotics adoption as livestock producers seek healthier production systems and improved feed efficiency. Domestic demand encourages innovation in microbial and plant-based feed additives tailored to commercial farming operations.
Germany emphasizes eubiotics that enhance feed conversion and animal welfare across commercial livestock operations. Manufacturers continue developing scientifically validated formulations aligned with evolving regulatory expectations and sustainable farming practices.
France supports eubiotics through livestock nutrition strategies focused on digestive health and responsible production practices. Feed manufacturers increasingly collaborate with producers to develop targeted additive solutions for multiple animal species.
Italy advances the eubiotics market by incorporating functional feed additives into poultry, swine, and ruminant nutrition programs. Manufacturers focus on product consistency and nutritional performance while supporting evolving animal health requirements.
Solid held the strongest position in the eubiotics market in 2025, accounting for a 63% share. This leadership is underpinned by the practical advantages of solid formulations in feed manufacturing and handling, where stability, easier storage, and compatibility with established mixing processes support routine commercial use. In the eubiotics market, these operational benefits help solid products remain the preferred option for large-scale livestock production, especially where consistency and shelf-life reliability are critical purchasing considerations.
Liquid is the fastest-growing form in the eubiotics market as producers seek more flexible delivery formats that can be integrated efficiently into water-based administration systems and precision feeding practices. Its momentum is underpinned by the need for faster application, easier dose adjustment, and better suitability in production environments where rapid response and uniform distribution are valued. Compared with solid alternatives, liquid formulations are experiencing stronger uptake where operational adaptability matters more than conventional handling familiarity.
Application Segment Analysis: Gut Health (Largest Segment) vs Immunity (Fastest-Growing Segment)
In 2025, gut health remained the largest application in the eubiotics market, with a 37.1% share. Its leadership reflects the central role of digestive performance in animal production, where feed utilization, nutrient absorption, and overall productivity are closely tied to intestinal balance. This makes gut health a core area of demand in the eubiotics market, as producers continue to prioritize applications that directly support day-to-day production efficiency and animal performance outcomes.
Immunity is emerging as the fastest-growing application in the eubiotics market as livestock producers place greater emphasis on strengthening natural defense mechanisms under changing production and health management conditions. Growth in this segment is being influenced by the practical need for solutions that help animals maintain resilience, particularly when preventive health approaches are becoming more important in routine production systems. Relative to more established applications, immunity is gaining momentum because it aligns closely with evolving expectations around health support beyond basic digestive optimization.
| Report Segmentation | |||
| Segment | Sub-Segment | Largest Segment | Fastest Growing Segment |
|---|---|---|---|
| Form | Liquid, Solid | Solid | Liquid |
| Application | Gut Health, Immunity, Yield, Others | Gut Health | Immunity |
| Product | Probiotics, Prebiotics, Organic Acids, Phytogenic, Enzymes | Probiotics | Phytogenic |
| End-use | Cattle Feed, Poultry Feed, Swine Feed, Aquatic Feed, Others | Poultry Feed | Swine Feed |
1. BASF SE (Germany)
2. Cargill Incorporated (United States)
3. Koninklijke DSM N.V. (Netherlands)
4. Evonik Industries AG (Germany)
5. Chr. Hansen Holding A/S (Denmark)
6. Novozymes A/S (Denmark)
7. Kemin Industries Inc. (United States)
8. Lesaffre Group (France)
9. Biomin Holding GmbH (Austria)
10. Bluestar Adisseo Company (China)
The eubiotics market is gaining momentum due to rising focus on gut health and animal nutrition optimization. Scientific advancements are improving microbial balance solutions for feed efficiency. The eubiotics market is expanding as demand for sustainable and antibiotic-alternative solutions increases globally.
| Competitive Dynamics and Strategic Insights | ||
| Assessment Parameter | Assigned Scale | Scale Justification |
|---|---|---|
| Market Concentration | Medium | The market features a mix of established players and new entrants, leading to moderate concentration levels. |
| M&A Activity / Consolidation Trend | Active | Increased interest from major agribusiness firms in acquiring innovative startups indicates a strong consolidation trend. |
| Degree of Product Differentiation | High | Products in the eubiotics market are highly differentiated based on formulation, efficacy, and target species. |
| Competitive Advantage Sustainability | Durable | Established brands maintain durable competitive advantages through strong R&D capabilities and brand loyalty. |
| Innovation Intensity | High | Continuous advancements in biotechnology and formulations drive high innovation intensity in the sector. |
| Customer Loyalty / Stickiness | Moderate | While some customers exhibit loyalty, the presence of numerous alternatives leads to moderate stickiness. |
| Vertical Integration Level | Medium | Some players are vertically integrated, but many still rely on third-party suppliers for raw materials. |
| Company Name | Date | Key Development |
|---|---|---|
| dsm-firmenich Animal Nutrition & Health | Aug-25 | dsm-firmenich ANH commissioned a new feed additives manufacturing facility in Jadcherla, India, expanding its production footprint for eubiotics and related solutions. The site integrates production and warehousing infrastructure and is designed to strengthen regional supply capabilities while supporting rising demand for gut health and mycotoxin risk-management solutions in livestock nutrition markets. |
| Evonik | Apr-25 | Evonik launched Ecobiol, a Bacillus subtilis-based probiotic for poultry gut health improvement in China. The product targets feed efficiency and intestinal health enhancement, reflecting increasing demand for functional and sustainable eubiotics in livestock production systems, particularly in high-growth Asian poultry markets focused on antibiotic reduction strategies. |
| Novus International | Jan-25 | Novus International partnered with Resilient Biotics to develop microbial feed solutions targeting immune health and respiratory performance in swine. The collaboration focuses on microbiome-based approaches designed to improve gut and respiratory function, supporting antibiotic-free livestock production trends and advancing biologically driven eubiotics innovation in animal health applications. |
| Novus International | Oct-24 | Novus International and Ginkgo Bioworks formed a partnership to develop next-generation feed additives, initially focusing on enzyme-based solutions to enhance livestock health and productivity. The collaboration strengthens innovation capabilities in microbial and biotech-enabled eubiotics, supporting improved feed efficiency and broader adoption of advanced biologically derived animal nutrition solutions. |
| Huvepharma | Mar-26 | Huvepharma launched Huvezym neXo, a fibre-degrading enzyme complex for poultry and swine feed applications. The product combines multiple cellulases and xylanase to improve digestion of high-fibre feed ingredients, enhancing nutrient availability and feed efficiency in livestock production systems using alternative raw materials and cost-optimized feed formulations. |
| Orffa | Dec-25 | Orffa launched its Elovital portfolio of amino acids and vitamins at Poultry India 2025 in Hyderabad, expanding its feed additive offerings across poultry, aquaculture, and livestock segments. The portfolio targets improved feed consistency and nutritional efficiency, strengthening Orffa’s position in high-growth South Asian animal nutrition markets. |
| Evonik | Jan-25 | Evonik launched Ecobiol Soluble Plus, a water-soluble probiotic for poultry at Poultry India 2025 in Hyderabad. The solution is designed to enhance gut health, nutrient absorption, and pathogen resistance in poultry production systems, reinforcing Evonik’s focus on sustainable feed additive innovation and microbiome-based performance improvement. |
| Novibio Inc. | Dec-24 | Novibio Inc. launched Poultrirom Plus, a feed additive product designed to improve intestinal health in broilers and turkeys. The development reflects continued expansion in gut health-focused eubiotics solutions aimed at enhancing poultry productivity and supporting digestive health management in commercial livestock production systems. |
| DSM-Firmenich | Dec-21 | DSM-Firmenich acquired Midori USA, Inc., a biotechnology start-up specializing in next-generation eubiotics platforms, expanding its animal nutrition portfolio. The acquisition strengthens DSM’s capabilities in microbiome-based feed solutions and complements its existing eubiotics assets, reinforcing its strategic position in advanced livestock health and nutrition technologies. |
The market size of the eubiotics is estimated at USD 6.63 billion in 2026.
Eubiotics Market size is anticipated to rise from USD 6.16 billion in 2025 to USD 14.32 billion by 2035 reflecting a CAGR surpassing 8.8% over the forecast horizon of 2026-2035.
Antibiotic restrictions are prompting feed producers to integrate probiotics, prebiotics, organic acids, and phytogenics into routine nutrition programs. This shift supports standardized adoption, long-term supplier relationships, and greater emphasis on gut health and disease resilience.
Producers increasingly favor targeted eubiotic formulations tailored to species, production stage, and health objectives. This data-driven approach improves feed efficiency, gut integrity, and immune performance while strengthening integration into commercial nutrition strategies.
Solid formulations held a 63% share in 2025 because they provide stability, easier storage, and compatibility with established feed manufacturing and mixing processes for large-scale livestock production.
Immunity is the fastest-growing application as livestock producers increasingly prioritize solutions that strengthen natural defenses and support preventive health management alongside productivity goals.
Europe leads through its mature animal nutrition industry, advanced feed production systems, strong adoption of gut health solutions, and structured regulatory environment supporting consistent commercial use.
Asia Pacific is forecast to grow at a 9.94% CAGR as livestock and aquaculture production expand, encouraging wider adoption of organized feed practices and health-supportive nutritional formulations.
Key players in the eubiotics market include BASF SE (Germany), Cargill, Incorporated (United States), Koninklijke DSM N.V. (Netherlands), Evonik Industries AG (Germany), Chr. Hansen Holding A/S (Denmark), Novozymes A/S (Denmark), Kemin Industries, Inc. (United States), Lesaffre Group (France), Biomin Holding GmbH (Austria), Bluestar Adisseo Company (China).